- MRes/MPhil: 2:2 (or international equivalent)
- PhD/DM: 2:1 (or international equivalent), plus a registrable medical qualification for DM; evidence of research activity, including BMedSci or BSc degrees, will be an advantage
Months of entry
We have research programmes in obstructive lung diseases (Asthma/COPD), fibrotic lung diseases (IPF, LAM) and infective lung diseases (cystic fibrosis, pneumonia). Our research focuses on genetics, pharmacogenetics, molecular pathophysiology, translational research (including biomarkers and imaging) and clinical trials.
We have close links on respiratory themes with researchers within other research groupings in Nottingham such as epidemiology, molecular microbiology, drug discovery, allergy, immunology and child health. We are part of several major national/international collaborations (eg MRCMAP COPD, NIHR TRP in inflammatory diseases and UBIOPRED IMI consortia) working closely with major academic institutions and industry. We host the National Centre for research into lymphangiolyomyomatosis (LAM).
We are a large respiratory research group with 10 senior academic staff at professor and associate professor levels, and more than 70 clinical and basic scientists including 10 senior staff based on both the City and QMC campuses. We have state of the art laboratories and a purpose built clinical trials unit, the Nottingham Respiratory Research Unit (NRRU) on the City campus.
Qualification and course duration
Course contact details
- Postgraduate Enquiries
- +44 (0)115 951 5559